HY-P99891-1mg
|
MedChemexpress LLC
|
Rovelizumab [CAS 339086-79-2]
|
|
Neuroscience-Neuromodulation
|
|
HY-P99891-10mg
|
MedChemexpress LLC
|
Rovelizumab [CAS 339086-79-2]
|
|
Neuroscience-Neuromodulation
|
|
HY-P99891-5mg
|
MedChemexpress LLC
|
Rovelizumab [CAS 339086-79-2]
|
|
Neuroscience-Neuromodulation
|
|
HY-W011777-500mg
|
MedChemexpress LLC
|
Tricaine (methanesulfonate) [CAS 886-86-2]
|
|
Neuroscience-Neuromodulation
|
|
HY-W011777-1mL
|
MedChemexpress LLC
|
Tricaine (methanesulfonate) [CAS 886-86-2] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
HY-128879A-10mg
|
MedChemexpress LLC
|
VP3.15 (dihydrobromide) [CAS 1281681-33-1]
|
|
Neuroscience-Neuromodulation
|
|
HY-128879A-100mg
|
MedChemexpress LLC
|
VP3.15 (dihydrobromide) [CAS 1281681-33-1]
|
|
Neuroscience-Neuromodulation
|
|
HY-128879A-25mg
|
MedChemexpress LLC
|
VP3.15 (dihydrobromide) [CAS 1281681-33-1]
|
|
Neuroscience-Neuromodulation
|
|
HY-128879A-5mg
|
MedChemexpress LLC
|
VP3.15 (dihydrobromide) [CAS 1281681-33-1]
|
|
Neuroscience-Neuromodulation
|
|
HY-128879A-50mg
|
MedChemexpress LLC
|
VP3.15 (dihydrobromide) [CAS 1281681-33-1]
|
|
Neuroscience-Neuromodulation
|
|
HY-128879A-1mL
|
MedChemexpress LLC
|
VP3.15 (dihydrobromide) [CAS 1281681-33-1] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
HY-14951-10mg
|
MedChemexpress LLC
|
Firategrast [CAS 402567-16-2]
|
|
Neuroscience-Neuromodulation
|
|
HY-14951-100mg
|
MedChemexpress LLC
|
Firategrast [CAS 402567-16-2]
|
|
Neuroscience-Neuromodulation
|
|
HY-14951-25mg
|
MedChemexpress LLC
|
Firategrast [CAS 402567-16-2]
|
|
Neuroscience-Neuromodulation
|
|
HY-14951-5mg
|
MedChemexpress LLC
|
Firategrast [CAS 402567-16-2]
|
|
Neuroscience-Neuromodulation
|
|
HY-14951-50mg
|
MedChemexpress LLC
|
Firategrast [CAS 402567-16-2]
|
|
Neuroscience-Neuromodulation
|
|
HY-14951-1mL
|
MedChemexpress LLC
|
Firategrast [CAS 402567-16-2] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|